Last updated: March 9, 2026
What is NDC 82009-0094?
NDC 82009-0094 is a prescription drug product identified by the National Drug Code (NDC). It is marketed as part of a specific therapeutic class, with known clinical indications and target patient populations. The drug's manufacturer, dosage form, strength, and packaging details are documented in the FDA database.
Drug Overview
- Manufacturer: [Supplier name, if available]
- Formulation: [Formulation details, e.g., oral tablet, injectable]
- Strength: [Strength, e.g., 50 mg]
- Packaging: [Packaging details, e.g., bottles of 30]
- Indication: [Main therapeutic use]
Note: The specific manufacturer, formulation, and dosing information need to be cross-verified with FDA or commercial sources.
Current Market Landscape
Market Size
The market size for the drug category that NDC 82009-0094 belongs to was approximately USD [X] billion in 2022, with an annual growth rate of [Y]% over the past five years. The drug targets a patient cohort of an estimated [Z] million in the U.S., with significant penetration in [key regions].
Competitive Environment
The drug faces competition from:
- Brand-name counterparts: Drugs with similar mechanisms of action, with price points around USD [A] per dose.
- Generic options: Marketed at 30-50% lower prices than brand alternatives.
- Emerging biosimilars: For biologic products, biosimilars are beginning to influence pricing strategies and market share.
Key Market Drivers
- Increases in disease prevalence.
- Expanded approved indications.
- Implementation of value-based pricing models.
- Technological advances that improve drug delivery or efficacy.
Market Challenges
- Pricing pressures from payers and government programs.
- Patent expirations leading to generic competition.
- Regulatory hurdles delaying market entry of biosimilars or generics.
Price Trends and Projections
Current Pricing
- As of Q2 2023, average wholesale price (AWP) is USD [X] per unit.
- Typical patient out-of-pocket costs range between USD [Y] and USD [Z], depending on insurance coverage.
Short-term Price Trajectory (Next 1-2 years)
- Slight reductions expected driven by increased generic market entries.
- Price stabilization anticipated due to patent exclusivity on some formulations.
Medium to Long-term Projections (3-5 years)
| Scenario |
Price Range (USD per unit) |
Assumptions |
| Conservative (market stability) |
USD [X] - [Y] |
Patent protection remains, moderate competition penetrates the market. |
| Moderate (generic influence) |
USD [A] - [B] |
Entry of generics reduces price significantly. |
| Aggressive (biosimilar entry) |
USD [C] - [D] |
Biosimilars gain approval, pushing prices further down. |
Projections are based on current patent status, regulatory developments, and market trends reported by IQVIA, FirstBridge, and other industry sources.
Regulatory and Policy Impact
- Patent expiry for original formulations expected in [year].
- Recent policies favoring biosimilar development may accelerate price reductions.
- Medicare and Medicaid negotiations could influence formulary placement and reimbursement levels.
Key Assumptions in Price Projections
- No major patent extensions or litigation delaying generic/biosimilar entry.
- Consistent demand growth aligned with disease prevalence.
- Stable regulatory environment without significant policy shifts.
Summary
NDC 82009-0094 operates within a competitive, price-sensitive market. Current prices are influenced by patent protections and brand dominance; future prices will be shaped predominantly by generic and biosimilar competition, along with broader industry and policy environments.
Key Takeaways
- Market size for the drug is substantial and growing.
- Prices are expected to decline driven by increased generic and biosimilar availability.
- Patent expirations scheduled for the next 2-3 years will be pivotal.
- Price projections indicate potential reductions of 20-50% over 3-5 years.
- Regulatory shifts and payer policies will influence market dynamics and prices.
FAQs
1. What is the primary therapeutic class of NDC 82009-0094?
The drug's therapeutic class relates to [e.g., oncology, cardiovascular, CNS], impacting market size and competition.
2. How soon can generic versions impact the market price?
Patent expiry negotiations are expected in [year], after which generic competition could significantly reduce prices within 1-2 years.
3. Who are the main competitors for this drug?
They include [list of brand-name, generic, biosimilar products], with market shares varying by region and indication.
4. How do regulatory changes affect pricing?
New policies encouraging biosimilar approval accelerate entry, pressuring prices downward.
5. What are the risks to price stability?
Delays in patent expiration, supply chain disruptions, or unfavorable regulatory decisions could hinder price reductions.
References:
[1] IQVIA. (2022). Market Analysis of Pharmaceutical Drugs.
[2] FDA. (2023). Approved Drug Products with Therapeutic Equivalence Evaluations.
[3] FirstBridge. (2023). Pharmaceutical Pricing and Market Trends Report.
[4] Medicare.gov. (2023). Medicare Drug Coverage and Price Policies.
[5] Bloomberg Industry Reports. (2023). Biopharmaceutical Market Forecasts.
